Robert Iannone

The latest quote from Robert Iannone is: “We are disappointed that tremelimumab monotherapy did not demonstrate a survival benefit in this patient population with no approved medicines beyond first-line treatment. However, we remain confident in tremelimumab's clinical activity in combination.”. It comes from the Closely watched AstraZeneca cancer drug fails in mesothelioma article. You’ll find on this page 1 article with Robert Iannone quoted on topics such as tremelimumab and population. Robert Iannone has been quoted 1 times in 1 article.

Robert Iannone quotes

Automatically powered by

We are disappointed that tremelimumab monotherapy did not demonstrate a survival benefit in this patient population with no approved medicines beyond first-line treatment. However, we remain confident in tremelimumab's clinical activity in combination.

No quotes...
More Robert Iannone quotes
|< <
{{currentQuotePage}}/{{numberPage}}
> >|
<
>